Current Report Filing (8-k)

Date : 07/31/2019 @ 8:19PM
Source : Edgar (US Regulatory)
Stock : STAAR Surgical Company (STAA)
Quote : 34.9  0.0 (0.00%) @ 8:59AM

Current Report Filing (8-k)

U N IT E D S T A T ES

S E C U R IT I E S A N D E X CHA N GE CO M MISSION

WAS H IN G TON, DC 2 0549

 

 

FORM 8-K

 

CURRENT REPORT

P u r s u a n t t o S e c tion 13 or 15(d) of t h e S ec u r ities Excha n ge A c t of 1934

 

Da t e of re p o r t ( D a t e of e a r l i e st e v e n t r e p o r t e d) : July 31, 2019

 

 

 

STAAR Surgical Company

( Ex act N a m e of Re g i s trant a s S p ecified i n Charter)

 

 

 

Delaware

0-11634

95-3797439

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

1911 Walker Ave.,

Monrovia, California

 

91016

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: 626-303-7902

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Che c k t he a ppropr iate bo x b e l o w i f the F o r m 8 - K f il i n g is i n ten d ed to s i mult a ne o u sl y sati s f y t he f il i ng ob l i gati o n o f the r egistr a nt un d er a n y o f t he f o ll o w i n g pro visi o ns ( s ee G e ne r al I n s tructi o n A . 2 . b el o w ) :

 

Wr itten c o mm u n icati o n p u r s u a n t to R u le 42 5 un d er t h e Se c u r ities A ct (1 7 C F R 230 . 4 2 5 )

 

S o liciting m ate r ial p u r s u a n t to Ru le 14 a - 1 2 u n d er t h e E x c h a ng e A ct (1 7 C F R 240 . 14 a - 12)

 

P re - c o mm e n c e m e n t c o m m u n i c a ti o n p u r s u a n t to Ru le 14 d - 2(b ) un d er t h e E x c h a n g e A ct (1 7 C FR 240 . 14 d - 2( b ) )

 

P re - c o mm e n c e m e n t c o m m u n i c a ti o n p u r s u a n t to Ru le 13 e - 4 ( c) un d er t h e E x c h a ng e A c t (1 7 C FR 240 . 13 e - 4( c ) )

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  

E m e r g i n g g r o w t h c o m p a n y

 

If an e m er g i ng g r o w th c o m p a n y , i n dicate b y c h e c k m ark i f t h e re g istra n t h as elected n ot to us e t h e e x t e n ded tra ns i t ion period f or co m p l y i n g w i th a ny n e w or re v i s ed f i n a n cial accou n t i ng s t a n da r ds pro v ided p u r su a n t to S ection 13(a) of t h e E x c h a n g e A ct.

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common

STAA

NASDAQ


 

Item 2.02    Results of Operations and Financial Condition

 

On July 31, 2019, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended June 28, 2019, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

 

Item 7.01 Regulation FD Disclosure.

 

On July 31, 2019, the Company also issued a press release announcing the submission of its multi-site European pivotal clinical trial data for the EVO+ Visian® ICL with Aspheric (EDOF) Optic to DEKRA, the Company’s European Notified Body. A copy of the press release is furnished as Exhibit 99.2 to this Report and is incorporated herein by this reference.

 

 

  This information and the information contained in these press releases shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in Items 2.02 and 7.01 of this Current Report, and Exhibits 99.1 and 99.2 are not incorporated by reference into any filings of STAAR made under the Securities Act of 1933, as amended, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing unless specifically stated so therein .

 

Item 9.01 Financial Statements and Exhibits

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

STAAR Surgical Company 

 

July 31, 2019

By:

/s/ Caren Mason

 

 

Caren Mason

 

 

President and Chief Executive Officer

 

 

 

STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart

1 Year : From Nov 2018 to Nov 2019

Click Here for more STAAR Surgical Charts.

STAAR Surgical (NASDAQ:STAA)
Intraday Stock Chart

Today : Friday 15 November 2019

Click Here for more STAAR Surgical Charts.

Latest STAA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.